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Abstract
The role of the WDR3 gene on genomic instability has been evaluated in a group of 115 differentiated thyroid cancer (DTC)
patients. Genomic instability has been measured according to the response of peripheral blood lymphocytes to ionizing
radiation (0.5 Gy). The response has been measured with the micronucleus (MN) test evaluating the frequency of
binucleated cells with MN (BNMN), both before and after the irradiation. No differences between genotypes, for the BNMN
frequencies previous the irradiation, were observed. Nevertheless significant decreases in DNA damage after irradiation
were observed in individuals carrying the variant alleles for each of the three genotyped SNPs: rs3754127 [28.85 (215.01 to
22.70), P,0.01]; rs3765501 [28.98 (215.61 to 22.36), P,0.01]; rs4658973 [28.70 (214.94 to 22.46), P,0.01]. These values
correspond to those obtained assuming a dominant model. This study shows for the first time that WDR3 can modulate
genome stability.
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Introduction
Chromosome region 1p12 has been associated to different types
of cancer, including differentiated thyroid carcinoma (DTC) [1,2].
Previous studies conducted by our group in this region have found
that the WDR3 gene, mapped in this region, shows a significant
association with DTC, suggesting its implication in the aetiology of
thyroid cancer [3].
Little information exists on the role of WDR3, but it is known
that it belongs to a family of eukaryotic genes carrying WD repeats
[4]. WD repeats are minimally conserved regions of approximately
40 amino acids, typically bracketed by Gly-His and Trp-Asp,
which may facilitate formation of heterotrimeric or multiprotein
complexes. Since WD-repeat proteins do not exist in prokaryotic
genomes, it is assumed that probably they arose in the immediate
precursors of eukaryotes [5]. Proteins belonging to the WD repeat
family are involved in a variety of cellular processes; including cell
cycle progression, signal transduction, apoptosis, and gene
regulation [6]. Regarding to the WDR3 gene, it should be
mentioned that it encodes a nuclear protein of 943 amino acids
containing 10 WD repeats [4]. This gene is involved in cell cycle
progression and signal transduction [7] and, although the specific
function of WDR3 is unknown, a role in ribosome biogenesis has
recently been reported [8].
Since neither of the functions attributed to WDR3 can be
specifically associated with thyroid cancer, we hypothesized that
perhaps it is involved in more general mechanisms maintaining
genomic stability. Consequently, variations in the WDR3 function
associated with the existence of genetic polymorphisms can
generate genome instability that can result in an increased cancer
risk. In this context, it must be indicated that ribosomal proteins
have been reported to be also involved in maintaining genome
integrity [9].
Although genomic instability is a complex parameter, a general
characteristic of individuals showing diseases such as Fanconi’s
anemia or ataxia telangiectasia is a poor response against agents
affecting the integrity of the genome, as it is the case of ionizing
radiation (IR). Thus, radiosensitivity is considered a biomarker of
genomic instability [10]. To determine if a candidate gene is
involved in genomic stability it must be demonstrated that cells
carrying different genetic polymorphisms are particularly sensitive
in front of the IR action.
Here, we evaluated the relationship between three non-coding
single nucleotide polymorphisms of the WDR3 gene and the
frequency of micronucleus, both spontaneous and after IR
exposure. The study has been carried out in peripheral blood
lymphocytes from a group of 115 DTC patients, and the levels of
DNA damage have been evaluated by using the cytokinesis-block
micronucleus assay (CBMN), because it is a well-established
cytogenetic technique with many advantages over other cytoge-
netic approaches. In this context, it must be stressed that it has
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been well demonstrated that CBMN assay is very useful as a
marker of spontaneous and induced DNA damage [11–13].
Materials and Methods
Ethic statement
The study was approved by the Ethic Committees from the
Hospital Universitari Vall d’Hebron in Barcelona, and the
Hospital Universitari Doctor Josep Trueta in Girona (Spain).
Population studied
The study was carried out in a total of 115 thyroid cancer
patients, 93 (81%) women and 22 (19%) men, recruited from both
the Hospital Universitari Vall d’Hebron in Barcelona, and the
Hospital Universitari Doctor Josep Trueta in Girona (Spain). The
average age at diagnosis was 43.30615.07 (mean 6 SD) years and
49.76616.49 when the sample was obtained. According to the
tumour-type, 99 (86%) of patients were classified as papillary and
16 (14%) as follicular.
Blood samples were collected prior to iodine treatment (131I),
after obtaining a written informed consent of all patients. All
participants completed a questionnaire, covering standard demo-
graphic questions, as well as a brief occupational, medical, and
family history. The histological classification of the tumour was
obtained from the medical records. All participants signed a
written consent.
Cell culture and treatment with IR
The cytokinesis-block micronucleus assay (CBMN) was carried
out using the cytochalasin B technique and following a standard
procedure [14]. Blood samples were taken by venipuncture and
0.5 mL of heparinised blood was diluted with 4.5 mL of complete
culture medium consisting of RPMI 1640, supplemented with
15% foetal bovine serum, 1% antibiotics (penicillin and strepto-
mycin) and 1% l-glutamine; all chemical were obtained from PAA
Laboratories GmbH, Pasching, Austria. Lymphocytes were
stimulated to divide with 1% phytohaemagglutinin (PHA) (Gibco
San Diego, USA) immediately after the treatment with IR.
Four cultures were established per each donor. Two were
irradiated with 0.5 Gy 137Cs c-rays, while the other two remain
untreated. Irradiation was carried out at the Unitat Te`cnica de
Proteccio´ Radiolo`gica (UTPR-UAB) of the Universitat Auto`noma
de Barcelona. The dose rate was 6.00 Gy min21. Lymphocytes
(irradiated and non-irradiated) were cultured at 37uC for
72 hours. At 44 hours after PHA stimulation, 10 mL (3 mg/mL)
of cytochalasin B (Sigma-Aldrich, St. Louis, USA) was added to
give a final concentration in culture of 6 mg/mL. Cultures were
maintained at 37uC and 5% CO2.
Cell harvesting and MN scoring
Cells were collected by centrifugation (10 min at 120 g). The
supernatant was discarded after each centrifugation. The hypo-
tonic treatment was carried out adding 5 mL of KCl 0.075 M at
4uC for 10 min. Next, cells were centrifuged and a methanol/
acetic acid mixture (3:1 v/v) was gently added. This fixation step
was repeated twice and the resulting cells were re-suspended in a
small volume of fixative solution. Air-dried preparations were
made and the slides were stained with 10% Giemsa (Merck
Table 1. Spontaneous and after irradiation BNMN
frequencies, according to gender and histological DTC type.
Patients (n)
Spontaneous
BNMN
(mean ± SE) Pa
BNMN after
irradiation
(mean ± SE) Pb
Total (115) 6.8760.55 31.3561.51
Female (93) 7.1960.65 0.339 31.1961.70 0.833
Male (22) 5.5160.94 31. 0163.11
Papillary (99) 6.6460.57 0.559 31.7161.50 0.553
Follicular (16) 8.3161.32 29.1365.53
aWilcoxon signed rank test.
bStudent’s t-tests.
doi:10.1371/journal.pone.0044288.t001
Figure 1. Correlation between DNA damage values (spontane-
ous vs after irradiation).
doi:10.1371/journal.pone.0044288.g001
Table 2. Differences for basal DNA damage (BNMN),
according to WDR3 polymorphisms.
Genotype N
mean BNMN
± SE
Difference
(95% CI)* P
rs3754127 C/C 39 8.3861.25 0 0.34
C/T 55 6.0760.63 21.77
(24.13 to 0.59)
T/T 21 6.1460.97 20.94
(24.03 to 2.15)
rs3765501 G/G 35 8.9461.36 0 0.28
G/A 43 6.4260.78 21.84
(24.47 to 0.78)
A/A 30 5.7060.72 22.12
(25.04 to 0.80)
rs4658973 T/T 39 8.3861.25 0 0.41
T/G 53 6.1360.65 21.65
(24.06 to 0.76)
G/G 21 6.2460.95 21.15
(24.24 to 1.95)
SE: standard error; CI: confidence interval.
*Adjusted by gender, age and diagnosis.
doi:10.1371/journal.pone.0044288.t002
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KGaA, Darmstadt, Germany) in phosphate buffer (pH 6.8) for
7 min. Slides were coded by a person does not involved in the
scoring.
To detect the level of genetic damage, the frequency of
binucleated cells with micronuclei (BNMN) was evaluated. A
blinded scoring of 1000 binucleated cells per sample (irradiated
and non-irradiated) were analyzed to determine the presence of
micronuclei, according to standard criteria [14].
SNP selection
The polymorphisms used in this study were selected according
to our previous analyses [3]. Thus, we selected three tag SNPs
showing haplotype association with thyroid cancer, rs3754127 (C/
T, 59 near gene), rs3765501 (G/A, intron) and rs4658973 (T/G,
intron).
DNA extraction and SNP genotyping
DNA was isolated from peripheral blood, using the standard
phenol-chloroform method. The SNP genotyping was performed
at the Centro Nacional de Genotipado (CeGen) using the iPLEX
(Sequenom) technique and it was successfully genotyped according
to the quality control criteria of the CeGen (http://www.cegen.
org). To assure the genotyping reliability, 10% of the samples were
randomly selected and double genotyped by replicates in multiple
96 well plates. In addition, two HapMap reference trios were
incorporated in plates and the genotype concordance and correct
Mendelian inheritance were verified.
Statistical analysis
The analysis of differences, linkage disequilibrium and haplo-
type frequency estimation were performed using the web tool for
SNP analysis SNPStats [15]. Linear regression model for
dominant and codominant inheritance were performed. All
analyses were adjusted for age, gender and histological diagnosis.
Haplotype analyses were performed using the same web tool.
Haploview software [16] was used to examine the LD between
SNPs. Other statistical analysis were done using R version 2.12.1
[17].
Results
General characteristics of the selected DTC patients are
summarized in the Material and Methods section. As indicated,
the proportion of women was higher than that of men, reflecting
the highest incidence of DTC in women. In addition, the elevated
Table 3. Differences for basal DNA damage, according to WDR3 haplotypes.
rs3754127 rs3765501 rs4658973 Frequency Difference (95% CI) P
1 C G T 0.5226 0 –
2 T A G 0.4217 20.74 (22.26 to 0.78) 0.34
3 C A T 0.0513 21.96 (25.15 to 1.23) 0.23
rare * * * 0.0043 25.79 (216.98 to 5.39) 0.31
Global haplotype association P-value: 0.31.
doi:10.1371/journal.pone.0044288.t003
Table 4. Differences for after-irradiation DNA damage, according to WDR3 polymorphisms.
Genotype N mean BNMN ± SE
Difference
(95% CI)* P
rs3754127 C/C 39 37.4662.91 0 0.021C
C/T 55 27.8761.77 29.24 (215.76 to 22.71)
T/T 21 29.163.55 27.77 (216.31 to 0.77)
C/C 39 37.4662.91 0 0.0057D
C/T-T/T 76 28.2161.6 28.85 (215.01 to 22.70)
rs3765501 G/G 35 38.0963.17 0 0.034C
G/A 43 29.1462.07 28.77 (216.03 to 21.51)
A/A 30 28.3362.73 29.33 (217.41 to 21.24)
G/G 35 38.0963.17 0 0.0091D
G/A-A/A 73 28.8161.65 28.98 (215.61 to 22.36)
rs4658973 T/T 39 37.4662.91 0 0.025C
T/G 53 27.8961.82 29.23 (215.87 to 22.59)
G/G 21 29.7163.55 27.30 (215.84 to 1.23)
T/T 39 37.4662.91 0 0.0074D
T/G-G/G 74 28.4161.64 28.70 (214.94 to 22.46)
SE: standard error; CI: confidence interval.
*Adjusted by gender, age and diagnosis.
C, D: Codominant and Dominant models, respectively.
doi:10.1371/journal.pone.0044288.t004
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incidence of the papillary thyroid cancer indicates the predomi-
nance of this histological subtype.
Table 1 shows that the mean of spontaneous BNMN frequency
in the 115 patients was 6.8760.55 (mean 6 SE). The BNMN
values showed a 4.6 fold increase (31.3561.5) after exposure to
0.5 Gy of ionizing radiation, regarding to the spontaneous levels.
These differences between the spontaneous and after irradiation
BNMN frequency were, as expected, statistically significant
(P,0.001). Moreover, although the mean of spontaneous BNMN
was higher in females (7.1960.65) than in males (5.5160.94) this
difference did not attain statistical significance (P = 0.339). On the
other hand, no differences were observed between females and
males after irradiation (31.1961.70 and 31.0163.11; respectively,
P = 0.833).
The spontaneous BNMN values in the subtype of patients with
papillary thyroid cancer showed a slight but not significant
decrease, in comparison with the follicular subtype (6.6460.57
and 8.3161.82; respectively, P = 0.559). The values of BNMN
after irradiation neither shown significant differences between
both subtypes (31.7161.50 and 29.1365.53; respectively,
P = 0.553).
In Figure 1 it is observed the good correlation that exists
between the spontaneous BNMN values and those observed after
the irradiation (R2 = 0.28, P,0.001). This would indicate an
underlying genetic cause.
We have also evaluated the cellular proliferation rate using the
cytokinesis-blocked proliferation index (CBPI). The CBPI value
indicates the average number of cell cycles per cell [18]. The
results (data not shown) indicate a significant decrease of CBPI in
cultures exposed to ionizing radiation (P,0.001).
The differences and their 95% confidence intervals were
calculated by linear regression analyses using as a reference the
homozygous genotype for the most frequent allele, with adjust-
ment for age, gender and diagnoses. Table 2 shows the differences
observed on spontaneous BNMN values, according to the different
polymorphisms, taking into account the codominant model of
inheritance. For the spontaneous BNMN frequency small differ-
ences between genotypes were found for all the evaluated
polymorphisms. Interestingly, in all the cases the BNMN values
were higher in the reference genotypes (homozygous for the
common allele), but these differences did not attain statistical
significances.
Haplotype analysis was performed for the three SNPs of WDR3
and the results are indicated in Table 3. Three haplotypes were
predicted to have a frequency .0.01. The other haplotypes were
predicted to be too odd for meaningful statistical analysis. No
significant differences were observed for any of the most frequent
haplotypes with the spontaneous BNMN values.
The means for the BNMN frequencies were significantly
different by genotype among the three WDR3 polymorphisms
(Table 4). We observed significantly lower mean BNMN
frequencies in the presence of the minor allele after ionizing
radiation exposure suggesting a dominant model of inheritance.
For example, the rs3754127 C/T-T/T genotypes showed a
decreased BNMN frequency compared with CC individuals (see
Table 4). Similarly, we also found a decrease in the radiation-
induced damage by haplotype when combining the minor allele of
each of the three genotyped SNPs [24.9 (29.16 to 20.63),
P = 0.026] (see Table 5).
When the analysis was performed stratifying the population by
the type of tumour at diagnosis (follicular or papillary), the
papillary subgroup showed values after irradiation similar to those
of the overall population: rs3754127 [28.39 (214.45 to 22.33),
P,0.01]; rs3765501 [28.83 (215.37 to 22.29), P,0.01];
rs4658973 [28.36 (214.46 to 22.27), P,0.01], all for the
dominant model. On the other hand, the effect observed for the
follicular subtype after irradiation was higher than in papillary and
in the overall DTC patients; however, the differences were not
statistically significant, probably due to low numbers of individ-
uals: rs3754127 [227.78 (255.54 to 20.02), P = 0.074];
rs3765501 [228.67 (262.46 to 5.12), P = 0.12]; rs4658973
[229.10 (260.26 to 2.06), P = 0.094], all for dominant model.
Discussion
In this study we have shown a significant relationship between
the three selected polymorphisms of the WDR3 gene and the levels
of DNA damage after a treatment with IR. This would indicate a
role of WDR3 in the maintenance of genomic stability.
WDR3 gene encodes a nuclear protein containing 10 WD
repeats with unknown function [4] and the members of this large
family are structurally related, but functionally diverse. Some of
the cellular functions or pathways regulated by the members of this
family includes gene regulation, signal transduction, RNA
processing and splicing, lymphocyte homing, regulation of cell
cycle progression, cell division/chromatin separation, and cell/
tissue differentiation, among other, as reviewed [5,6]. However, up
to now there is not information indicating a possible involvement
with repair mechanisms or influence, in the maintenance of
genomic stability for WDR3, or for any member of its family.
Aiming to find a reasonable explanation for the association
observed between WDR3 polymorphisms and DTC incidence, we
have already reported the up-regulation of WRD3 in different
thyroid cancer cell lines, suggesting its possible implication in
thyroid cancer tumorigenesis [3]. This would agree with the
studies carried out in the breast carcinoma cell line MCF-7
showing that the suppression of WDR3 reduce cell proliferation,
decrease cell size and reduce foci formation, indicating that WDR3
confers a growth and proliferative advantage on cancer cells [8].
The WDR3 protein is redistributed within the nucleus when
ribosome biogenesis is disrupted. Cellular events appear to be
influenced by the regulation of expression of WDR3 altering
Table 5. Differences for after-irradiation DNA damage, according to WDR3 haplotypes.
rs3754127 rs3765501 rs4658973 Frequency Difference (95% CI) P-value
1 C G T 0.5227 0 –
2 T A G 0.4217 24.9 (29.16 to 20.63) 0.026
3 C A T 0.0512 23.74 (212.73 to 5.26) 0.42
rare * * * 0.0043 4.21 (227.15 to 35.58) 0.79
Global haplotype association P-value: 0.79.
doi:10.1371/journal.pone.0044288.t005
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ribosome biogenesis [8]. Decreased transient changes on the levels
of DNA-damage repair proteins (non-homologous end-joining
proteins) have been observed in the nucleolus after ionizing
radiation exposure; therefore, it seems possible that these
alterations reflect a biologically relevant response to DNA
double-strand break damage [19].
Our findings suggest a correlation between the minor frequency
alleles for rs3754127, rs3765501, rs4658973 polymorphisms and
lower values of DNA damage, after the treatment with ionizing
radiation. Although the SNPs used in our study do not produce
changes of amino acids in the protein sequence, it is known that
non-coding single nucleotide polymorphisms may alter gene
expression [20]. Modifications near the promoter sequence
(rs3754127) can interrupt the correct interaction with transcription
factors changing totally the gene expression or influencing the level
of expression [21]; this means that the transcription of WDR3
could depend of genetic variance at its promoter region. Although
alternative splicing, due to the presence of SNPs, probably occur
[22,23], it must be pointed out that alternative transcripts are also
induced by ionizing radiation [24]. Thus, polymorphisms at
rs3765501 and/or rs4658973 may also influence alternative
splicing, not only because of its presence but also by additional
or differential effects with the ionizing radiation effects. Alterna-
tively, any of these polymorphisms may be responsible for the
decrease of DNA damage after IR, but they act as genetic markers
of genetic variants of WDR3 directly involved in the WDR3
genomic stability.
The observed effects, indicating the involvement of WDR3 in
maintaining genomic stability after the exposure to IR, would
agree with the association found with DTC and with the role
attributed in the ribosome biogenesis. Thus, alterations in the
expression of WDR3 would disrupt the signalling pathways that
exist between ribosome biogenesis and p53 activation [8]. All these
results altogether suggest an important role of WDR3 in
maintaining genome stability as well as in carcinogenesis and cell
cycle regulation. Interesting, preliminary results with colon cancer
patients (V. Moreno, personal communication) seem to indicate an
altered expression of WDR3 in colon cancer, supporting our view,
proposing a role of WDR3 in genomic stability and cancer. Our
data are interesting enough to carry out additional studies in
WDR3 gene expression to confirm this hypothesis.
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